Shanghai Haohai Biological Technology Co., Ltd. Class H (HK:6826) has released an update.
Shanghai Haohai Biological Technology Co., Ltd. has announced an increase in registered capital from RMB168,707,203 to RMB235,489,895 following the issuance of 66,782,692 new shares, as part of its 2023 Profit Distribution and Capital Reserve Capitalization Plan. The company’s total shares have risen to 235,489,895, prompting proposed amendments to its Articles of Association. Shareholders will vote on these changes at an upcoming extraordinary general meeting.
For further insights into HK:6826 stock, check out TipRanks’ Stock Analysis page.
